Y-Intercept (HK)’s Centessa Pharmaceuticals CNTA Stock Holding History

Y-Intercept (HK)’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-96,367	Closed	-$3.83M	–	1778
2026 Q1	$3.83M	Buy	96,367 +84,926	+742%	+$2.17M	0.07%	431
2025 Q4	$286K	Buy	+11,441	New	+$290K	0.01%	1378
2025 Q3	–	Sell	-46,665	Closed	-$613K	–	1626
2025 Q2	$613K	Buy	+46,665	New	+$591K	0.02%	1132

Y-Intercept (HK)'s CNTA Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 96,367 shares — an estimated $3.83M sold.

Y-Intercept (HK) first reported a position in CNTA in Q2 2025 and held it in 3 quarters. The position peaked at $3.83M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Y-Intercept (HK) reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 96,367 Centessa Pharmaceuticals shares in Q2 2026, an estimated $3.83M.
Y-Intercept (HK) first reported a position in Centessa Pharmaceuticals in Q2 2025 and held it in 3 quarters.
Y-Intercept (HK)'s Centessa Pharmaceuticals position peaked at $3.83M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.